Research analysts at Craig Hallum began coverage on shares of Teladoc Inc. (NYSE:TDOC) in a research note issued to investors on Monday. The brokerage set a “buy” rating on the stock.

TDOC has been the subject of several other reports. Deutsche Bank AG decreased their price objective on shares of Teladoc from $21.00 to $20.00 and set a “buy” rating for the company in a research note on Thursday, August 4th. FBR & Co decreased their price objective on shares of Teladoc from $34.00 to $28.00 and set an “outperform” rating for the company in a research note on Thursday, August 4th. Oppenheimer Holdings Inc. set a $23.00 price objective on shares of Teladoc and gave the stock a “buy” rating in a research note on Sunday, October 30th. Zacks Investment Research downgraded shares of Teladoc from a “hold” rating to a “sell” rating in a research note on Tuesday, September 20th. Finally, Chardan Capital assumed coverage on shares of Teladoc in a research note on Wednesday, November 16th. They set a “buy” rating and a $24.00 price objective for the company. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating and eleven have issued a buy rating to the company’s stock. Teladoc currently has an average rating of “Buy” and a consensus target price of $22.91.

Analyst Recommendations for Teladoc (NYSE:TDOC)

Shares of Teladoc (NYSE:TDOC) opened at 18.15 on Monday. The firm’s market capitalization is $835.48 million. The company’s 50-day moving average is $16.69 and its 200 day moving average is $15.86. Teladoc has a 52 week low of $9.08 and a 52 week high of $22.00.

Teladoc (NYSE:TDOC) last issued its quarterly earnings results on Thursday, October 27th. The company reported ($0.33) EPS for the quarter, topping the consensus estimate of ($0.36) by $0.03. Teladoc had a negative net margin of 69.15% and a negative return on equity of 32.68%. The firm earned $32.40 million during the quarter, compared to analyst estimates of $32.29 million. During the same quarter in the prior year, the business posted ($0.35) earnings per share. Teladoc’s revenue for the quarter was up 62.0% compared to the same quarter last year. Analysts anticipate that Teladoc will post ($1.42) EPS for the current fiscal year.

COPYRIGHT VIOLATION NOTICE: This news story was originally published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this news story on another publication, it was illegally copied and republished in violation of international copyright and trademark laws. The original version of this news story can be read at https://www.thecerbatgem.com/2016/11/28/teladoc-inc-tdoc-coverage-initiated-at-craig-hallum.html.

In other Teladoc news, VP Mark Hirschhorn sold 5,000 shares of the stock in a transaction on Thursday, November 10th. The shares were sold at an average price of $17.50, for a total transaction of $87,500.00. Following the transaction, the vice president now directly owns 267,687 shares in the company, valued at approximately $4,684,522.50. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Company insiders own 5.94% of the company’s stock.

Several hedge funds have recently modified their holdings of TDOC. US Bancorp DE boosted its stake in shares of Teladoc by 31.7% in the second quarter. US Bancorp DE now owns 7,507 shares of the company’s stock worth $120,000 after buying an additional 1,805 shares during the period. American International Group Inc. boosted its stake in shares of Teladoc by 109.4% in the second quarter. American International Group Inc. now owns 11,945 shares of the company’s stock worth $191,000 after buying an additional 6,240 shares during the period. UBS Asset Management Americas Inc. boosted its stake in shares of Teladoc by 9.5% in the third quarter. UBS Asset Management Americas Inc. now owns 12,050 shares of the company’s stock worth $221,000 after buying an additional 1,050 shares during the period. Credit Suisse AG boosted its stake in shares of Teladoc by 4.3% in the third quarter. Credit Suisse AG now owns 12,055 shares of the company’s stock worth $221,000 after buying an additional 498 shares during the period. Finally, Airain ltd acquired a new stake in shares of Teladoc during the second quarter worth $200,000. 53.34% of the stock is currently owned by institutional investors.

About Teladoc

Teladoc, Inc, together with its subsidiaries, is a telehealth company. The Company offers telehealth platform, delivering on-demand healthcare anytime, anywhere, through mobile devices, the Internet, video and phone. The Company operates through health services segment. Its solution connects its Members, with its over 3,000 board-certified physicians and behavioral health professionals who treat a range of conditions and cases from acute diagnoses, such as upper respiratory infection, urinary tract infection and sinusitis to dermatological conditions, anxiety and smoking cessation.

5 Day Chart for NYSE:TDOC

Receive News & Stock Ratings for Teladoc Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Inc. and related stocks with our FREE daily email newsletter.